Skip to main content

Home/ Cancer/ Group items tagged pain

Rss Feed Group items tagged

Matti Narkia

Benefits of Vitamin D Supplementation - Journal of American Physicians and Surgeons Vol... - 0 views

  •  
    Benefits of Vitamin D Supplementation
    Joel M. Kauffman, Ph.D.
    Journal of American Physicians and Surgeons
    Volume 14 Number 2 - Summer 2009

    Clinical trials show that vitamin D supplementation at higher
    levels than previously recommended is beneficial for many
    conditions. It decreases the frequency of falls and fractures, helps
    prevent cardiovascular disease, and reduces symptoms of colds or
    influenza. Benefits are also seen in diabetes mellitus, multiple
    sclerosis, Crohn disease, pain, depression, and possibly autism.
    Sunlight does not cause an overdose of vitamin D production,
    and toxicity from supplementation is rare. Dose recommendations
    are increasing, but appear to be lagging the favorable trial results. A
    number of common drugs deplete vitamin D levels, and others may
    limit its biosynthesis from sunlight.
    People with adequate levels from sun exposure will not benefit
    from supplementation. While dietary intake is helpful,
    supplementation is better able to raise serum 25-hydroxyvitamin D ,
    the major circulating metabolite, to the level now thought adequate,
    30-50 ng/mL.
    Where there is inadequate daily sun exposure, oral doses of
    1,000-2,000 IU/d are now considered routine, with much higher
    doses (up to 50,000 IU) for rapid repletion now considered safe.
Matti Narkia

Cannabinoids and cancer: causation, remediation, and palliation : The Lancet Oncology - 0 views

  •  
    Cannabinoids and cancer: causation, remediation, and palliation.
    Hall W, Christie M, Currow D.
    Lancet Oncol. 2005 Jan;6(1):35-42. Review.
    PMID: 15629274
    doi:10.1016/S1470-2045(04)01711-5
Matti Narkia

Cannabinoids: potential anticancer agents : Abstract : Nature Reviews Cancer - 0 views

  •  
    Cannabinoids: potential anticancer agents.
    Guzmán M.
    Nat Rev Cancer. 2003 Oct;3(10):745-55. Review.
    PMID: 14570037
    doi:10.1038/nrc1188
Matti Narkia

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agent... - 0 views

  •  
    Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
    Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M.
    Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31.
    PMID: 19285265
    doi:10.1016/j.beem.2009.02.001    
1 - 4 of 4
Showing 20 items per page